Xconomy | Boston - Business + Technology in the Exponential Economy

Life Sciences, people, VC

Fetzer New CEO of Cerulean Pharma

Ryan McBride 4/8/09

Oliver Fetzer has been named the new CEO of Cerulean Pharma, a Cambridge, MA-based developer of nanoparticle-based drugs for cancer and other diseases, according to the company. Fetzer, who was previously senior vice president of corporate development and R&D at Lexington, MA-based Cubist Pharmaceuticals (NASDAQ:CBST), is taking over the chief executive post from veteran biotech executive and venture capitalist Alan Crane. Crane, who is the founding CEO of Cerulean and a venture partner at Polaris Venture Partners in Waltham, MA, has been named the biotech’s chairman of the board. Polaris is an investor in Cerulean.

Ryan McBride is Xconomy's correspondent. You can reach him at rmcbride@xconomy.com, or follow him on Twitter at http://twitter.com/Ryan_McBride.


Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.